8.07
3.86%
+0.30
Axogen Inc. stock is currently priced at $8.07, with a 24-hour trading volume of 172.08K.
It has seen a +3.86% increased in the last 24 hours and a -21.88% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $7.71 pivot point. If it approaches the $8.10 resistance level, significant changes may occur.
Axogen Inc. Stock (AXGN) Financials Data
Axogen Inc. (AXGN) Revenue 2023
AXGN reported a revenue (TTM) of $152.25 million for the quarter ending September 30, 2023, a +13.66% rise year-over-year.
Axogen Inc. (AXGN) Net Income 2023
AXGN net income (TTM) was -$23.24 million for the quarter ending September 30, 2023, a +19.37% increase year-over-year.
Axogen Inc. (AXGN) Cash Flow 2023
AXGN recorded a free cash flow (TTM) of -$24.05 million for the quarter ending September 30, 2023, a +40.83% increase year-over-year.
Axogen Inc. (AXGN) Earnings per Share 2023
AXGN earnings per share (TTM) was -$0.56 for the quarter ending September 30, 2023, a +16.42% growth year-over-year.
Axogen Inc. Stock (AXGN) Latest News
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial Results
GlobeNewswire Inc.
Zacks.com featured highlights Protagonist Therapeutics, AxoGen, Western Digital and Phunware
Zacks Investment Research
Ekso Bionics (EKSO) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
4 Must-Buy Stocks for Remarkable Earnings Acceleration
Zacks Investment Research
AxoGen (AXGN) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks Investment Research
About Axogen Inc.
AxoGen, Inc. develops and markets surgical solutions for peripheral nerve injuries. The company's surgical solutions include Avance Nerve Graft, an off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed nerves; and AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments. Its solutions also comprise Avive Soft Tissue Membrane, a minimally processed human umbilical cord membrane that can be used as a resorbable soft tissue covering to separate tissues and modulate inflammation in the surgical bed. In addition, the company offers AcroVal neurosensory and motor testing system, which consists of AcroGrip for use in hand grip strength measurement; AcroPinch for measuring pinch strength; and Pressure-Specified Sensory Device, a somatosensory evaluation and measurement device. Further, it provides AxoTouch two point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals in the United States, Canada, the United Kingdom and other European countries, and internationally. AxoGen, Inc. is headquartered in Alachua, Florida.
Cap:
|
Volume (24h):